AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 297: E665-E675, 2009. First published June 16, 2009; doi:10.1152/ajpendo.00115.2009
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/3/E665    most recent
00115.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Pehmøller, C.
Right arrow Articles by Wojtaszewski, J. F. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pehmøller, C.
Right arrow Articles by Wojtaszewski, J. F. P.

Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle

Christian Pehmøller,1,* Jonas T. Treebak,1,* Jesper B. Birk,1 Shuai Chen,2 Carol MacKintosh,2 D. Grahame Hardie,3 Erik A. Richter,1 and Jørgen F. P. Wojtaszewski1

1Molecular Physiology Group, Copenhagen Muscle Research Centre, Department of Exercise and Sport Sciences, University of Copenhagen, Copenhagen, Denmark; and 2MRC Protein Phosphorylation Unit and 3Division of Molecular Physiology, College of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom

Submitted 20 February 2009 ; accepted in final form 13 June 2009

TBC1D1 is a Rab-GTPase-activating protein (GAP) known to be phosphorylated in response to insulin, growth factors, pharmacological agonists that activate 5'-AMP-activated protein kinase (AMPK), and muscle contraction. Silencing TBC1D1 in L6 muscle cells by siRNA increases insulin-stimulated GLUT4 translocation, and overexpression of TBC1D1 in 3T3-L1 adipocytes with low endogenous TBC1D1 expression inhibits insulin-stimulated GLUT4 translocation, suggesting a role of TBC1D1 in regulating GLUT4 translocation. Aiming to unravel the regulation of TBC1D1 during contraction and the potential role of AMPK in intact skeletal muscle, we used EDL muscles from wild-type (WT) and AMPK kinase dead (KD) mice. We explored the site-specific phosphorylation of TBC1D1 Ser237 and Thr596 and their relation to 14-3-3 binding, a proposed mechanism for regulation of GAP function of TBC1D1. We show that muscle contraction increases 14-3-3 binding to TBC1D1 as well as phosphorylation of Ser237 and Thr596 in an AMPK-dependent manner. AMPK activation by AICAR induced similar Ser237 and Thr596 phosphorylation of, and 14-3-3 binding to, TBC1D1 as muscle contraction. Insulin did not increase Ser237 phosphorylation or 14-3-3 binding to TBC1D1. However, insulin increased Thr596 phosphorylation, and intriguingly this response was fully abolished in the AMPK KD mice. Thus, TBC1D1 is differentially regulated in response to insulin and contraction. This study provides genetic evidence to support an important role for AMPK in regulating TBC1D1 in response to both of these physiological stimuli.

5'-AMP-activated protein kinase; wortmannin; 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside; AMPK kinase dead; extensor digitorum longus muscle



Address for reprint requests and other correspondence: J. F. P. Wojtaszewski, Molecular Physiology Group, Dept. of Exercise and Sport Sciences, Copenhagen Muscle Research Centre, Univ. of Copenhagen, DK-2100, Copenhagen, Denmark (E-mail: jwojtaszewski{at}ifi.ku.dk)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.